Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

The Psoriasis, Atherosclerosis, and Cardiometabolic Disease Initiative (PACI)

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2016 by National Institutes of Health Clinical Center (CC)
Sponsor:
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Heart, Lung, and Blood Institute (NHLBI) )
ClinicalTrials.gov Identifier:
NCT01778569
First received: January 26, 2013
Last updated: October 21, 2016
Last verified: October 2016